CPC
GMED icon

Cookson Peirce & Co’s Globus Medical GMED Stock Holding History

Cookson Peirce & Co’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,693
Closed -$283K – 221
2021
Q3 		$283K Buy
+3,693
New +$297K 0.02% 182
2019
Q1 		– Sell
-191,258
Closed -$8.28M – 152
2018
Q4 		$8.28M Sell
191,258
-8,190
-4% -$409K 0.8% 41
2018
Q3 		$11.3M Buy
199,448
+2,388
+1% +$126K 0.91% 37
2018
Q2 		$9.94M Buy
197,060
+9,950
+5% +$519K 0.89% 41
2018
Q1 		$9.32M Buy
+187,110
New +$8.79M 0.84% 41

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Cookson Peirce & Co's GMED Position: Q4 2021 in Review

Cookson Peirce & Co sold out of Globus Medical (GMED) in Q4 2021, closing a stake of 3,693 shares — an estimated $283K sold.

Cookson Peirce & Co first reported a position in GMED in Q1 2018 and held it in 5 quarters. The position peaked at $11.3M in Q3 2018. 373 funds tracked by Wall St. Rank hold GMED as of Q4 2021.

  • Cookson Peirce & Co reported no remaining Globus Medical position as of Q4 2021 after selling out during the quarter.
  • Cookson Peirce & Co sold 3,693 Globus Medical shares in Q4 2021, an estimated $283K.
  • Cookson Peirce & Co first reported a position in Globus Medical in Q1 2018 and held it in 5 quarters.
  • Cookson Peirce & Co's Globus Medical position peaked at $11.3M in Q3 2018.
  • 373 funds tracked by Wall St. Rank held Globus Medical as of Q4 2021.

Based on Cookson Peirce & Co's 13F filing for Q4 2021, filed 31 Jan 2022.